{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:23:20Z","timestamp":1790083400427,"version":"4.0.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Dementia with Lewy Bodies (DLB) is the second most common cause of neurodegenerative dementia after Alzheimer\u2019s disease (AD), but the field is still lacking a specific biomarker for its core pathology: alpha synuclein (\u03b1-syn). Realtime quaking induced conversion (RT-QuIC) has recently emerged as a strong biomarker candidate to detect misfolded \u03b1-syn in DLB. However, the variability in the parameters of the technique and the heterogeneity of DLB patients make the reproducibility of the results difficult. Here, we provide an overview of the state-of-the-art research of \u03b1-syn RT-QuIC in DLB focused on: (1) the capacity of \u03b1-syn RT-QuIC to discriminate DLB from controls, Parkinson\u2019s disease (PD) and AD; (2) the capacity of \u03b1-syn RT-QuIC to identify prodromal stages of DLB; and (3) the influence of co-pathologies on \u03b1-syn RT-QuIC\u2019s performance. We also assessed the influence of different factors, such as technical conditions (e.g., temperature, pH, shaking-rest cycles), sample type, and clinical diagnosis versus autopsy confirmation.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We conducted a systematic review following the PRISMA guidelines in August 2022, without any limits in publication dates. Search terms were combinations of \u201cRT-QuIC\u201d and \u201cLewy Bodies,\u201d \u201cDLB\u201d or \u201cLBD\u201d.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our meta-analysis shows that \u03b1-syn RT-QuIC reaches very high diagnostic performance in discriminating DLB from both controls (pooled sensitivity and specificity of 0.94 and 0.96, respectively) and AD (pooled sensitivity and specificity of 0.95 and 0.88) and is promising for prodromal phases of DLB. However, the performance of \u03b1-syn RT-QuIC to discriminate DLB from PD is currently low due to low specificity (pooled sensitivity and specificity of 0.94 and 0.11). Our analysis showed that \u03b1-syn RT-QuIC\u2019s performance is not substantially influenced by sample type or clinical diagnosis versus autopsy confirmation. Co-pathologies did not influence the performance of \u03b1-syn RT-QuIC, but the number of such studies is currently limited. We observed technical variability across published articles. However, we could not find a clear effect of technical variability on the reported results.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> There is currently enough evidence to test misfolded \u03b1-syn by RT-QuIC for clinical use. We anticipate that harmonization of protocols across centres and advances in standardization will facilitate the clinical establishment of misfolded \u03b1-syn detection by RT-QuIC.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1193458","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T05:29:21Z","timestamp":1684301361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Carmen","family":"Pe\u00f1a-Bautista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Ch\u00e1fer-Peric\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Abelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-021-01175-w","article-title":"Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"9","author":"Bargar","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/acn3.50897","article-title":"\u03b1-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"6","author":"Bongianni","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40478-021-01276-6","article-title":"Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"9","author":"Brockmann","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","article-title":"Seeding variability of different alpha synuclein strains in synucleinopathies","volume":"85","author":"Candelise","year":"2019","journal-title":"Ann. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-019-0181-9","article-title":"Effect of the micro-environment on \u03b1-synuclein conversion and implication in seeded conversion assays","volume":"9","author":"Candelise","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"B6","doi-asserted-by":"publisher","first-page":"20914","DOI":"10.1073\/pnas.0710152105","article-title":"Prion detection by an amyloid seeding assay","volume":"104","author":"Colby","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/pathogens10030305","article-title":"The latest research on RT-QuIC assays\u2014a literature review","volume":"10","author":"Dong","year":"2021","journal-title":"Pathogens"},{"key":"B8","doi-asserted-by":"publisher","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: Dementia with Lewy bodies and Parkinson disease dementia","volume":"22","author":"Gomperts","year":"2016","journal-title":"CONTINUUM Lifelong Learn. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC","volume":"6","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-022-01388-7","article-title":"Performance of \u03b1Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease","volume":"10","author":"Hall","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/19336896.2020.1724608","article-title":"RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy","volume":"14","author":"Han","year":"2020","journal-title":"Prion"},{"key":"B14","doi-asserted-by":"publisher","first-page":"584536","DOI":"10.3389\/fnsyn.2020.584536","article-title":"From synaptic protein to prion: The long and controversial journey of \u03b1-synuclein","volume":"12","author":"Heras-Garvin","year":"2020","journal-title":"Front. Synaptic Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","article-title":"Detection of \u03b1-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: A longitudinal observational study","volume":"20","author":"Iranzo","year":"2021","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","article-title":"APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology","volume":"143","author":"Jin","year":"2022","journal-title":"Acta Neuropathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbrc.2008.01.140","article-title":"Sequence determinants regulating fibrillation of human alpha-synuclein","volume":"368","author":"Koo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40336-016-0217-4","article-title":"Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neurites","volume":"5","author":"Kotzbauer","year":"2017","journal-title":"Clin. Transl. Imaging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"111842","DOI":"10.1016\/j.exger.2022.111842","article-title":"The promise of amplification assays for accurate early detection of \u03b1-synucleinopathies: A review","volume":"165","author":"Kurapova","year":"2022","journal-title":"Exp. Gerontol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/mds.28651","article-title":"RT-QuIC detection of pathological \u03b1-synuclein in skin punches of patients with Lewy body disease","volume":"36","author":"Mammana","year":"2021","journal-title":"Mov. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11481-019-09835-4","article-title":"Ultrasensitive detection of aggregated \u03b1-synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the RT-QuIC assay: New high-throughput neuroimmune biomarker assay for parkinsonian disorders","volume":"14","author":"Manne","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","article-title":"\u03b1-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients","volume":"35","author":"Manne","year":"2020","journal-title":"Mov. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1021\/bi400866w","article-title":"Conformational features of tau fibrils from Alzheimer\u2019s disease brain are faithfully propagated by unmodified recombinant protein","volume":"52","author":"Morozova","year":"2013","journal-title":"Biochemistry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"703984","DOI":"10.3389\/fnagi.2021.703984","article-title":"Development of \u03b1-synuclein real-time quaking-induced conversion as a diagnostic method for \u03b1-synucleinopathies","volume":"13","author":"Nakagaki","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4161\/pri.19430","article-title":"New generation QuIC assays for prion seeding activity","volume":"6","author":"Orru","year":"2012","journal-title":"Prion"},{"key":"B28","doi-asserted-by":"publisher","first-page":"fcab045","DOI":"10.1093\/braincomms\/fcab045","article-title":"Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"3","author":"Perra","year":"2021","journal-title":"Brain Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3233\/JAD-210342","article-title":"Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with Lewy bodies","volume":"82","author":"Pilotto","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/biom11060820","article-title":"RT-QuIC using C-terminally truncated \u03b1-synuclein forms detects differences in seeding propensity of different brain regions from synucleinopathies","volume":"11","author":"Poggiolini","year":"2021","journal-title":"Biomolecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","article-title":"Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies","volume":"145","author":"Poggiolini","year":"2022","journal-title":"Brain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","article-title":"Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes","volume":"7","author":"Quadalti","year":"2021","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies","volume":"140","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1212\/WNL.0000000000012438","article-title":"Diagnostic value of the CSF \u03b1-synuclein real-time quaking-induced conversion assay at the prodromal MCI stage of dementia with Lewy bodies","volume":"97","author":"Rossi","year":"2021","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1007\/s00415-021-10778-1","article-title":"Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus","volume":"269","author":"Sakurai","year":"2022","journal-title":"J. Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.celrep.2014.02.031","article-title":"Detection of misfolded a\u03b2 oligomers for sensitive biochemical diagnosis of Alzheimer\u2019s disease","volume":"7","author":"Salvadores","year":"2014","journal-title":"Cell Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1007\/s12035-017-0624-1","article-title":"Prion-like seeding of misfolded \u03b1-synuclein in the brains of dementia with Lewy body patients in RT-QUIC","volume":"55","author":"Sano","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2022.08.012","article-title":"In vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson\u2019s disease","volume":"103","author":"Shin","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s progression markers initiative cohort using \u03b1-synuclein seed amplification: A cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0166-2236(02)02195-1","article-title":"Cyclic amplification of protein misfolding: Application to prion-related disorders and beyond","volume":"25","author":"Soto","year":"2002","journal-title":"Trends Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tibs.2010.11.001","article-title":"Prion hypothesis: The end of the controversy?","volume":"36","author":"Soto","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/biom12040576","article-title":"RT-QuIC and related assays for detecting and quantifying prion-like pathological seeds of \u03b1-synuclein","volume":"12","author":"Srivastava","year":"2022","journal-title":"Biomolecules"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","article-title":"Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder","volume":"144","author":"Stefani","year":"2021","journal-title":"Brain"},{"key":"B45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","article-title":"Consensus report of the working group on: \"Molecular and biochemical markers of alzheimer's disease\". The Ronald and nancy reagan research Institute of the alzheimer's association and the national Institute on aging working group","volume":"19","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"B51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/alz.12814","article-title":"Dementia with Lewy bodies: Impact of co\u2010pathologies and implications for clinical trial design","volume":"19","author":"Toledo","year":"2022","journal-title":"Alzheimer\u2019s & Dement."},{"key":"B46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","article-title":"Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: A consensus paper from the Alzheimer\u2019s biomarkers standardization initiative","volume":"8","author":"Vanderstichele","year":"2012","journal-title":"Alzheimer\u2019s Dementia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","article-title":"Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies \u2013 current issues and future directions","volume":"150","author":"Walker","year":"2019","journal-title":"J. Neurochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.3311","article-title":"Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease","volume":"78","author":"Wang","year":"2021","journal-title":"JAMA Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1007\/s10072-022-06014-x","article-title":"Real-time quaking-induced conversion assay is accurate for Lewy body diseases: A meta-analysis","volume":"43","author":"Wang","year":"2022","journal-title":"Neurol. Sci."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1193458\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T05:29:24Z","timestamp":1684301364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1193458\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":50,"alternative-id":["10.3389\/fmolb.2023.1193458"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1193458","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"article-number":"1193458"}}